A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: the HOMAGE trial
21 May 2023 (15:00 - 15:45)
Organised by: 

Abstract
Slides
About the speaker

Tokyo Medical University, Tokyo (Japan)
6 More presentations in this session
Miss A. Moya (Aalst, BE)
Access the full session
The Event
Heart Failure 2023
21 May 2023
15:00 CET
You may be interested in
Congress Presentation


